I am Dr. Awanish Kumar, an Associate Professor in Department of Biotechnology at the National Institute of Technology (NIT) Raipur, India. I received my Ph.D. in Biotechnology, specializing in Molecular Parasitology, from Jawaharlal Nehru University (JNU), New Delhi, with experimental research conducted at the CSIR-Central Drug Research Institute (CDRI), Lucknow. Subsequently, I pursued postdoctoral research at McGill University, Canada.
My research focuses on understanding the molecular mechanisms underlying microbial pathogenesis and antimicrobial resistance, with the ultimate goal of developing innovative therapeutic strategies against infectious diseases. My major research interests include bacterial and fungal infections, particularly Salmonella Typhi and Candida albicans, antimicrobial resistance, microbial biofilms, molecular parasitology, target-based drug discovery, and the development of efficient drug-delivery systems.
My research contributions encompass antibiofilm strategies, enzyme-based therapeutics, antifungal agents, natural-product-derived antimicrobial compounds, and innovative approaches to overcoming drug resistance.
I am committed to mentoring young researchers, promoting interdisciplinary collaboration, and translating scientific discoveries into practical healthcare solutions. My long-term mission is to advance evidence-based, innovative, and accessible antimicrobial therapeutics while contributing to global fight against infectious diseases and AMR.
I am Dr. Awanish Kumar, an Associate Professor in Department of Biotechnology at the National Institute of Technology (NIT) Raipur, India. I received my Ph.D. in Biotechnology, specializing in Molecular Parasitology, from Jawaharlal Nehru University (JNU), New Delhi, with experimental research conducted at the CSIR-Central Drug Research Institute (CDRI), Lucknow. Subsequently, I pursued postdoctoral research at McGill University, Canada.
My research focuses on understanding the molecular mechanisms underlying microbial pathogenesis and antimicrobial resistance, with the ultimate goal of developing innovative therapeutic strategies against infectious diseases. My major research interests include bacterial and fungal infections, particularly Salmonella Typhi and Candida albicans, antimicrobial resistance, microbial biofilms, molecular parasitology, target-based drug discovery, and the development of efficient drug-delivery systems.
My research contributions encompass antibiofilm strategies, enzyme-based therapeutics, antifungal agents, natural-product-derived antimicrobial compounds, and innovative approaches to overcoming drug resistance.
I am committed to mentoring young researchers, promoting interdisciplinary collaboration, and translating scientific discoveries into practical healthcare solutions. My long-term mission is to advance evidence-based, innovative, and accessible antimicrobial therapeutics while contributing to global fight against infectious diseases and AMR.